Medmira Laboratories, Inc.
MedMira is dedicated to improving human health by providing the best in rapid diagnostics. Their patented Rapid Vertical Flow Technology™ delivers fast, accurate results for a range of applications, helping care providers and patients know more, instantly.
Industries
Nr. of Employees
medium (51-250)
Medmira Laboratories, Inc.
Patents
Products
Rapid whole-blood HIV antibody test (FDA-cleared)
A point-of-care rapid immunoassay providing near-instant HIV antibody results from whole blood, developed for clinical and point-of-care use.
Multiplex rapid tests for HIV, hepatitis B/C and syphilis (CE marked)
Combination rapid immunoassays that detect multiple infectious disease markers simultaneously on a single test for screening and point-of-care settings.
Research and development toolkits for diagnostic developers
Kits and supporting materials to enable researchers and developers to build and commercialize new rapid diagnostic tests using the vertical flow platform.
Rapid whole-blood HIV antibody test (FDA-cleared)
A point-of-care rapid immunoassay providing near-instant HIV antibody results from whole blood, developed for clinical and point-of-care use.
Multiplex rapid tests for HIV, hepatitis B/C and syphilis (CE marked)
Combination rapid immunoassays that detect multiple infectious disease markers simultaneously on a single test for screening and point-of-care settings.
Research and development toolkits for diagnostic developers
Kits and supporting materials to enable researchers and developers to build and commercialize new rapid diagnostic tests using the vertical flow platform.
Services
Toolkits and platform components to support development of new rapid diagnostic assays and combination tests for research and commercialization.
Supply and market distribution of point-of-care rapid diagnostic tests for infectious diseases.
Toolkits and platform components to support development of new rapid diagnostic assays and combination tests for research and commercialization.
Supply and market distribution of point-of-care rapid diagnostic tests for infectious diseases.
Expertise Areas
- Rapid point-of-care diagnostics
- Multiplex immunoassay development
- Vertical flow immunoassay platform R&D
- Regulatory submissions and compliance (FDA, CE)
Key Technologies
- Vertical flow immunoassay
- Multiplex rapid immunoassays
- Whole-blood rapid antibody testing
- Point-of-care diagnostic platforms
News & Updates
MedMira Inc. reported its financial results for the three month period ending October 31, 2016.
MedMira Inc. reported its financial results for the quarter and year ended July 31, 2016.
MedMira Inc. reported its financial results for the three and nine month periods ending April 30, 2016.
MedMira Inc. reported its financial results for the quarter and year ended July 31, 2015.
MedMira Inc. reported its financial results for the three month period ending October 31, 2016.
MedMira Inc. reported its financial results for the quarter and year ended July 31, 2016.
MedMira Inc. reported its financial results for the three and nine month periods ending April 30, 2016.
MedMira Inc. reported its financial results for the quarter and year ended July 31, 2015.